title: Hematological interventions in NICU care: the use of rEpo, IVIG, and rG-CSF.
abstract: This article focuses on the use of rEpo, IVIG, and rG-CSF in the NICU. It discusses the most recent studies and the most definitive and clinically relevant evidence, rather than summarizing all published studies. The last section was written for NICU practice groups that choose to use any of these medications and are seeking a consistent approach for doing so. The section provides the author's approach to the use of rEpo, IVIG, and rG-CSF, revealing personal preferences, interpretations, and experiences, and is based on the dictum, "if you are going to use it, use it the same way each time."
authors.affiliation: Women and Newborns Program, Intermountain Healthcare, 36 South State Street, Salt Lake City, UT 84111, USA. Robert.christensen@imail.org
authors.forename: Robert D
authors.initials: RD
authors.lastname: Christensen
mesh_terms: D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000188:drug therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007239:Infections / Q000188:drug therapy; D007363:Intensive Care Units, Neonatal; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D016756:Immunoglobulins, Intravenous; D018696:Neuroprotective Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor